Tranquility Partners’s AstraZeneca AZN Stock Holding History

Tranquility Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Buy	1,492 +112	+8%	+$21.1K	0.1%	199
2026 Q1	$272K	Buy	+1,380	New	+$266K	0.1%	198
2023 Q1	–	Sell	-3,642	Closed	-$494K	–	208
2022 Q4	$494K	Hold	3,642	–	–	0.25%	107
2022 Q3	$399K	Hold	3,642	–	–	0.22%	115
2022 Q2	$481K	Buy	3,642 +924	+34%	+$121K	0.25%	113
2022 Q1	$361K	Hold	2,718	–	–	0.17%	138
2021 Q4	$317K	Sell	2,718 -150	-5%	-$17.6K	0.15%	153
2021 Q3	$344K	Hold	2,868	–	–	0.17%	143
2021 Q2	$344K	Buy	2,868 +93	+3%	+$10.2K	0.19%	133
2021 Q1	$276K	Buy	+2,775	New	+$279K	0.17%	149

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tranquility Partners's AZN Position: Q2 2026 in Review

Tranquility Partners increased its AstraZeneca (AZN) stake by 8.1% in Q2 2026, buying an estimated $21.1K and bringing the position to 1,492 shares worth $283K. The position accounts for 0.1% of the portfolio, ranked #199.

Tranquility Partners first reported a position in AZN in Q1 2021 and has held it in 10 quarters since. The position peaked at $494K in Q4 2022. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Tranquility Partners held 1,492 shares of AstraZeneca worth $283K as of Q2 2026.
Tranquility Partners bought 112 AstraZeneca shares in Q2 2026, an estimated $21.1K.
AstraZeneca made up 0.1% of Tranquility Partners's portfolio in Q2 2026, its #199 holding.
Tranquility Partners first reported a position in AstraZeneca in Q1 2021 and has held it in 10 quarters since.
Tranquility Partners's AstraZeneca position peaked at $494K in Q4 2022.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Tranquility Partners's 13F filing for Q2 2026, filed 23 Jul 2026.